Mark W. Kroll, Director at HAEMONETICS CORP (HAE), sold 11,772 shares at $102.00 ($1.1M) on 2020-04-09, disclosed to the SEC on 2020-04-13.
Open-market sale of $1.1M HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 870 | $0 | 0.0% |
| 2 | $102.00 | 4,329 | $442K | 39.7% |
| 3 | $102.00 | 6,573 | $670K | 60.3% |
| Total | $94.46 avg | 11,772 | $1.1M | 100% |
| Filing → |
| HAE | SELL | 2022-08-16 | $1.2M | — | Filing → |
| AXON | SELL | 2022-06-09 | $650K | — | Filing → |
| HAE | SELL | 2021-05-28 | $1.3M | — | Filing → |